Lataa...
A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
Patients with monoclonal gammopathy of renal significance should be treated with clone‐directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.
Tallennettuna:
| Julkaisussa: | Clin Case Rep |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7562843/ https://ncbi.nlm.nih.gov/pubmed/33088534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3044 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|